Battle Pits Patent Rights Against Low-Cost Generic Drugs (New York Times)
Battle Pits Patent Rights Against Low-Cost Generic Drugs (New York Times)
The supply of low-cost generic versions of cancer and AIDS treatments for the developing world could be blocked if Novartis wins a legal challenge to India?s patent law.